These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26739548)

  • 1. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes.
    Zhao X; Birchall JC; Coulman SA; Tatovic D; Singh RK; Wen L; Wong FS; Dayan CM; Hanna SJ
    J Control Release; 2016 Feb; 223():178-187. PubMed ID: 26739548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes.
    Arikat F; Hanna SJ; Singh RK; Vilela L; Wong FS; Dayan CM; Coulman SA; Birchall JC
    J Control Release; 2020 Jun; 322():593-601. PubMed ID: 32087298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of hydrophobic peptides for skin delivery via coated microneedles.
    Zhao X; Coulman SA; Hanna SJ; Wong FS; Dayan CM; Birchall JC
    J Control Release; 2017 Nov; 265():2-13. PubMed ID: 28286315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.
    Dul M; Nikolic T; Stefanidou M; McAteer MA; Williams P; Mous J; Roep BO; Kochba E; Levin Y; Peakman M; Wong FS; Dayan CM; Tatovic D; Coulman SA; Birchall JC;
    Int J Pharm; 2019 May; 562():303-312. PubMed ID: 30910633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
    Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
    Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.
    Singh RK; Malosse C; Davies J; Malissen B; Kochba E; Levin Y; Birchall JC; Coulman SA; Mous J; McAteer MA; Dayan CM; Henri S; Wong FS
    Nanomedicine; 2021 Feb; 32():102321. PubMed ID: 33184020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
    van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
    Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
    Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
    Smith EL; Peakman M
    Front Immunol; 2018; 9():392. PubMed ID: 29541078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to islet autoantigens in type 1 diabetes.
    Bach JF; Chatenoud L
    Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specific immunotherapy of autoimmune diseases through the nanomedicine.
    Verdaguer J
    Endocrinol Nutr; 2016 Nov; 63(9):437-439. PubMed ID: 27344428
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.
    Ali MA; Thrower SL; Hanna SJ; Coulman SA; Birchall JC; Wong FS; Dayan CM; Tatovic D
    Immunology; 2015 Nov; 146(3):411-22. PubMed ID: 26293297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes.
    Firdessa-Fite R; Johnson SN; Leon MA; Khosravi-Maharlooei M; Baker RL; Sestak JO; Berkland C; Creusot RJ
    Diabetes; 2021 Jun; 70(6):1334-1346. PubMed ID: 33468513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
    Filippi C; Bresson D; von Herrath M
    Int Rev Immunol; 2005; 24(5-6):341-60. PubMed ID: 16318986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.